⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29593111 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28323289 | 0.97 | NOS2 (0.44) | — | |
| SCHEMBL580504 | 0.79 | — | — | |
| SCHEMBL29626655 | 0.79 | — | — | |
| SCHEMBL35248 | 0.79 | — | — | |
| SCHEMBL30374657 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL28660209 | 0.77 | NOS2 (0.62) | — | |
| Hydrochloric Acid SCHEMBL9013637 | 0.77 | NOS2 (0.44) | — | |
| Hydrochloric Acid SCHEMBL7421394 | 0.77 | NOS2 (0.44) | — | |
| Ammonia Solution, Strong SCHEMBL28486618 | 0.77 | NOS2 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117247383-A | Pharmaceutical compounds, salts thereof, formulations thereof, and methods of making and using the same | 基因技术公司 | 2023-12-19 | — | — | CN | claimed |
| EP-3746441-A1 | PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATIONS THEREOF, AND METHODS OF MAKING AND USING SAME | GENENTECH, INC. (US) | 2020-12-09 | — | — | EP | claimed |
| CN-109382137-B | Preparation method and application of mesoporous Fe-Cu-SSZ-13 molecular sieve | 福州大学 | 2020-04-10 | — | — | CN | claimed |
| CN-107955161-B | Self-healing elastomer material based on reversible non-covalent bond effect and preparation method thereof | 华南理工大学 | 2020-02-18 | — | — | CN | claimed |
| WO-2019152863-A1 | PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATIONS THEREOF, AND METHODS OF MAKING AND USING SAME | GENENTECH, INC. (US) | 2019-08-08 | — | — | WO | claimed |
| CN-107955161-A | A kind of self-healing elastomeric material based on the effect of reversible non-covalent key and preparation method thereof | 华南理工大学 | 2018-04-24 | — | — | CN | claimed |
| WO-2025101780-A1 | PHARMACOLOGICAL CORRECTORS OF RHODOPSIN AND USES THEREOF | OCTANT, INC. (US) | 2025-05-15 | — | — | WO | disclosed |
| US-20240425448-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-12-26 | — | — | US | disclosed |
| WO-2024215070-A1 | PYRAZOLOPYRIDINE DERIVATIVE COMPOUND, AND USE THEREOF | 보로노이 주식회사 | 2024-10-17 | — | — | WO | disclosed |
| EP-4431490-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2024-09-18 | — | — | EP | disclosed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | disclosed |
| US-11964960-B2 | Pyridinone- and pyridazinone-based compounds and uses thereof | CORNELL UNIVERSITY (US) | 2024-04-23 | — | — | US | disclosed |
| WO-2024044344-A1 | PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| US-20060069116-A1 | 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | MERCK SHARP & DOHME LLC | 2006-03-30 | — | — | US | disclosed |
| WO-2005044793-A2 | NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-19 | — | — | WO | disclosed |
| US-6117893-A | Heterocyclic compounds having anti-diabetic activity and their use | SANKYO COMPANY, LIMITED (JP) | 2000-09-12 | — | — | US | disclosed |
| US-5962470-A | Heterocyclic compounds having anti-diabetic activity and their use | SANKYO COMPANY, LIMITED (JP) | 1999-10-05 | — | — | US | disclosed |
| US-5834501-A | TREATING DIABETES OR HYPERLIPEMIA | SANKYO COMPANY, LIMITED (JP) | 1998-11-10 | — | — | US | disclosed |
| CN-1118781-A | Heterocyclic compound with activity against diabetes and preparation and application of same | MITSUTAKA CO LTD (JP) | 1996-03-20 | — | — | CN | disclosed |
| US-5302601-A | Useful in the treatment of diseases mediated by platelet activating factor | G. D. SEARLE & CO. (US) | 1994-04-12 | — | — | US | disclosed |